JAGUAR HEALTH, INC. Other Receivables, Net, Current
JAGUAR HEALTH, INC. (JAGX) had Other Receivables, Net, Current of $190.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Notes
us-gaap:OtherReceivablesNetCurrent · last filed 2026-08-19
- 2026-06-30: Other Receivables, Net, Current $190.00K.
- 2026-03-31: Other Receivables, Net, Current $212.00K.
- 2025-12-31: Other Receivables, Net, Current $177.00K.
- 2025-09-30: Other Receivables, Net, Current $67.00K.
| Period end | Other Receivables, Net, Current | Other Receivables, Net, Current as first filed |
|---|---|---|
| 2026-06-30 | $190.00K 10-Q · filed 2026-08-19 | |
| 2026-03-31 | $212.00K 10-Q · filed 2026-05-20 | |
| 2025-12-31 | $177.00K 10-Q · filed 2026-08-19 | |
| 2025-09-30 | $67.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $143.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $166.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $120.00K 10-K · filed 2026-04-07 | |
| 2024-09-30 | $57.00K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $65.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $202.00K 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $217.00K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $171.00K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $161.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $457.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $588.00K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $634.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $526.00K 10-Q · filed 2022-08-22 | |
| 2022-03-31 | $460.00K 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $435.00K 10-K · filed 2023-03-24 | |
| 2021-09-30 | $94.00K 10-Q · filed 2021-11-17 | |
| 2021-06-30 | $40.00K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $30.00K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $28.00K 10-K · filed 2022-03-11 | |
| 2020-09-30 | $3.00K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $5.00K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $4.00K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $2.00K 10-K · filed 2021-03-31 | $2.87K 10-K · filed 2020-04-03 |
| 2019-06-30 | $92.74K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $2.30K 10-Q · filed 2019-05-21 | |
| 2018-12-31 | $6.12K 10-K · filed 2020-04-03 | |
| 2018-09-30 | $176.39K 10-Q · filed 2018-11-19 | |
| 2018-06-30 | $70.46K 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $2.41K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $1.38K 10-K · filed 2019-04-10 | |
| 2017-09-30 | $17.35K 10-Q · filed 2017-11-20 | |
| 2017-06-30 | $197.88K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $288.17K 10-Q/A · filed 2017-06-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |